Q98459371
Swedish report of a commission of inquiry from 2012
Press Enter · cited answer in seconds
0 sources
Q98459371
Summary
Q98459371 is an inquiry report[1].
Key Facts
- Q98459371 is in the country of Sweden[2].
- Q98459371's instance of is recorded as inquiry report[3].
- Q98459371's part of the series is recorded as Swedish government official reports 2012[4].
- Q98459371's language of work or name is recorded as Swedish[5].
- Q98459371's publication date is recorded as +2012-10-31T00:00:00Z[6].
- Q98459371's main subject is recorded as medication[7].
- Q98459371's work available at URL is recorded as http://data.riksdagen.se/dokument/H0B375[8].
- Q98459371's work available at URL is recorded as http://data.riksdagen.se/dokumentstatus/H0B375[9].
- Q98459371's work available at URL is recorded as http://data.riksdagen.se/dokument/H0B375.pdf[10].
- Q98459371's applies to jurisdiction is recorded as Sweden[11].
- Q98459371's legal citation of this text is recorded as SOU 2012:75[12].
- Q98459371's title is recorded as Pris, tillgång och service, - fortsatt utveckling av läkemedels- och apoteksmarknaden[13].
- Q98459371's maintained by WikiProject is recorded as Project Riksdagen's documents[14].
- Q98459371's copyright status is recorded as public domain[15].
- Q98459371's Swedish Riksdag document ID is recorded as H0B375[16].